Company secures licence to export hand sanitiser to the US

Yorkshire-based pharmaceutical solutions provider, Origin, has been awarded a licence to export registered medical products to North America from the US Food and Drug Administration.

The Certificate of Drug Establishment Registration has been issued by Registrar Corp for alcohol-based antibacterial hand sanitiser gel.

Origin has secured an initial co-order of 15 million units which will be filled and packaged at its facility in Melton, East Yorkshire before being distributed to US partners.

Rich Quelch, global head of marketing at the company, said: “From the outset of the Covid-19 crisis, Origin has committed to help mitigate the devastating impact of the virus internationally.

“We’re delighted to be able to support the production of much-needed alcohol-based hand sanitiser gel in our state-of-the-art filling and packaging facility in East Yorkshire and receive FDA approval for US distribution.

“Origin has a long history of manufacturing and supplying healthcare packaging globally, and we’re very interested in expanding our relationships with partners for skincare, healthcare and pharma products in the U.S and other international markets.

“This FDA licence marks an important step forward in realising this goal.”

Demand for personal hygiene products continues to grow globally amid the ongoing pandemic, with the international hand sanitiser market expected to reach $1.87bn by the end of 2020.

This high demand has led to many retailers increasing the price of this commodity and new companies entering the market, particularly alcohol manufacturers.